Amgen launches new technology and innovation site in Hyderabad.

Amgen, the largest biotechnology company in the United States, has launched its new technology and innovation site in Hyderabad. The inauguration took place at Amgen's office campus near Hi-Tech City. This site opening marks a significant step toward expanding Amgen's benefits and impact on the technology industry both in India and internationally, aiming to further its growth. As part of its expansion in India, this project will bring a new perspective to the pharmaceutical sector. The Chief Minister of the State, A. Revanth Reddy, and the Minister for IT and Industries, D. Sridhar Babu, inaugurated the Amgen Innovation Site, giving the event added significance through their official presence.

At the inauguration, Robert A. Bradway, Chairman and CEO of Amgen, Jennifer Larson, Consul General of the United States, Som Chattopadhyay, Amgen India Representative, and Naveen Gullapalli, Managing Director of Amgen India, participated. They shared their experiences, discussed the uniqueness of Amgen, and explained how the company would bring new guidelines to the medical field in India, particularly in biotechnology, healthcare services, and research. The event also brought together key individuals who showed enthusiasm for research and development in India, further boosting the success of Amgen in the country and encouraging the growth of related industries.

As part of this expansion, Amgen plans to invest $200 million (approximately ₹1600 crores) by 2025. This is an encouraging signal for the development of the science and technology industry, the bio-pharma sector, and the health industry in India. More investments are planned in the coming years. Not only in Hyderabad but Amgen also intends to establish more research centers in other cities across India. These investments will significantly contribute to achieving government objectives by creating job opportunities. In the coming years, the company will launch more projects, generating employment across the country.

Amgen will expand its operations in the state to further develop its range of medicines. The new technology innovation site in Hyderabad will provide AI and data science-based digital capabilities. This site will facilitate digital transformation with modern technologies, inspiring progress in research, data analysis, and pharmaceutical research. Through this site, there will be opportunities to design solutions for innovations in the healthcare industry, data science, AI, operational efficiency, and pharmaceutical manufacturing, as well as enhance digital operations.

For more updates on business developments and innovations like this, visit Vaartha.